Article Information
History
- February 8, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 8, 2021 - 08:37).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Leonidas Stamatatos1,2,*,
- Julie Czartoski1,
- Yu-Hsin Wan1,
- Leah J. Homad1,
- Vanessa Rubin1,
- Hayley Glantz1,
- Moni Neradilek1,
- Emilie Seydoux1,
- Maedeline F. Jennewein1,
- Anna J. MacCamy1,
- Junli Feng1,
- Gregory Mize1,
- Stephen C. De Rosa1,3,
- Andrés Finzi4,5,6,
- Maria Lemos1,
- Kristen W. Cohen1,
- Zoe Moodie1,
- M. Juliana McElrath1,2,7,* and
- Andrew T. McGuire1,2,3,*
- 1Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA
- 2Department of Global Health, University of Washington, Seattle, WA, USA
- 3Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
- 4Centre de Recherche du CHUM, Montréal, QC, Canada
- 5Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada
- 6Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada
- 7Department of Medicine, University of Washington, Seattle, WA, USA QC, Canada
- ↵* Correspondence: amcguire{at}fredhutch.org; lstamata{at}fredhutch.org; jmcelrat{at}fredhutch.org;